For millions of individuals, the diagnosis of actinic keratoses (AK)—rough, scaly, sun-damaged skin patches—marks the beginning of...
Chemotherapy and Targeted Therapy
By Delilah Alvarado Published June 10, 2026 In a significant move that could reshape the treatment landscape...
In the high-stakes world of pharmaceutical development, the journey from laboratory bench to bedside is notoriously precarious....
In a significant development for dermatological care, Takeda Pharmaceutical has released clinical data that could reshape the...
In the early years of the smartphone revolution, the tech industry coined a mantra that would eventually...
By Gwendolyn Wu Published June 11, 2026 In a pivotal moment for both the Swiss pharmaceutical giant...
The golden age of American biotechnology—characterized by rapid venture capital deployment and a relatively predictable regulatory pathway—has...
In a significant tactical realignment, French biotechnology firm Sensorion has announced the immediate discontinuation of its gene...
Main Facts: The Strategic Pivot In a move that underscores the increasingly volatile nature of the biotechnology...
More than sixty years after Calvin Stevens first synthesized ketamine at Parke-Davis—a discovery initially intended to provide...
